vs
Performance Shipping Inc.(PSHG)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Performance Shipping Inc.的1.8倍($69.8M vs $39.5M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs 97.5%,领先286.5%),RIGEL PHARMACEUTICALS INC同比增速更快(21.2% vs -7.9%)
阿塞拜疆里海航运封闭式股份公司是阿塞拜疆国有航运企业,也常被简称为CASPAR(源自俄语缩写),主要围绕里海区域开展航运相关业务,是当地航运领域的核心国有企业。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
PSHG vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.8倍
$39.5M
营收增速更快
RIGL
高出29.1%
-7.9%
净利率更高
RIGL
高出286.5%
97.5%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $39.5M | $69.8M |
| 净利润 | $38.5M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 93.3% | 33.2% |
| 净利率 | 97.5% | 384.0% |
| 营收同比 | -7.9% | 21.2% |
| 净利润同比 | 78.1% | 1769.2% |
| 每股收益(稀释后) | $1.00 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PSHG
RIGL
| Q4 25 | — | $69.8M | ||
| Q3 25 | — | $69.5M | ||
| Q2 25 | $39.5M | $101.7M | ||
| Q1 25 | — | $53.3M | ||
| Q4 24 | — | $57.6M | ||
| Q3 24 | — | $55.3M | ||
| Q2 24 | $42.9M | $36.8M | ||
| Q1 24 | — | $29.5M |
净利润
PSHG
RIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | — | $27.9M | ||
| Q2 25 | $38.5M | $59.6M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | — | $12.4M | ||
| Q2 24 | $21.6M | $-1.0M | ||
| Q1 24 | — | $-8.2M |
毛利率
PSHG
RIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率
PSHG
RIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 40.9% | ||
| Q2 25 | 93.3% | 60.1% | ||
| Q1 25 | — | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | 49.1% | 1.2% | ||
| Q1 24 | — | -23.6% |
净利率
PSHG
RIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | — | 40.2% | ||
| Q2 25 | 97.5% | 58.6% | ||
| Q1 25 | — | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | — | 22.5% | ||
| Q2 24 | 50.4% | -2.8% | ||
| Q1 24 | — | -27.9% |
每股收益(稀释后)
PSHG
RIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | — | $1.46 | ||
| Q2 25 | $1.00 | $3.28 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | $0.55 | $-0.06 | ||
| Q1 24 | — | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $95.8M | $155.0M |
| 总债务越低越好 | $43.7M | $52.5M |
| 股东权益账面价值 | $312.8M | $391.5M |
| 总资产 | $363.8M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.14× | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
PSHG
RIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | $95.8M | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | $61.7M | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务
PSHG
RIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | $43.7M | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | $51.2M | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益
PSHG
RIGL
| Q4 25 | — | $391.5M | ||
| Q3 25 | — | $117.6M | ||
| Q2 25 | $312.8M | $81.9M | ||
| Q1 25 | — | $18.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | $254.0M | $-29.9M | ||
| Q1 24 | — | $-31.7M |
总资产
PSHG
RIGL
| Q4 25 | — | $513.6M | ||
| Q3 25 | — | $242.5M | ||
| Q2 25 | $363.8M | $206.7M | ||
| Q1 25 | — | $176.0M | ||
| Q4 24 | — | $164.0M | ||
| Q3 24 | — | $139.4M | ||
| Q2 24 | $310.5M | $128.4M | ||
| Q1 24 | — | $126.5M |
负债/权益比
PSHG
RIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | 0.14× | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.20× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $26.8M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.70× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
PSHG
RIGL
| Q4 25 | — | $22.0M | ||
| Q3 25 | — | $24.0M | ||
| Q2 25 | $26.8M | $30.5M | ||
| Q1 25 | — | $-893.0K | ||
| Q4 24 | — | $14.5M | ||
| Q3 24 | — | $21.7M | ||
| Q2 24 | $31.7M | $302.0K | ||
| Q1 24 | — | $-5.0M |
资本支出强度
PSHG
RIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — |
现金转化率
PSHG
RIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | 0.70× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | 1.47× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图